Serum GFAP is a diagnostic marker for glioblastoma multiforme

Brain

Volumn 130, Issue 12, 2007, Pages 3336-3341

  Jung, C S ^a,b   Foerch, C ^a   Schanzer A ^a   Heck, A ^a   Plate, K H ^a   Seifert, V ^a   Steinmetz, H ^a   Raabe, A ^a   Sitzer, M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Biomarker; GFAP; Glioblastoma; Serum

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ANAPLASTIC OLIGODENDROGLIOMA; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN DAMAGE; BRAIN METASTASIS; CANCER SURGERY; CENTRAL NERVOUS SYSTEM TUMOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIFFUSE ASTROCYTOMA; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; SUPRATENTORIAL MASS LESION; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 36749056259     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm263     Document Type: Article

References (40)

1. Abaza MS, Shaban F, Narayan RK, Atassi MZ. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity. Anticancer Res 1998; 18: 1333-40.
2. Blechingberg J, Holm IE, Nielsen KB, Jensen TH, Jorgensen AL, Nielsen AL. Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform. Glia 2007; 55: 497-507.
3. Bonnin JM, Rubinstein LJ. Immunohistochemistry of central nervous system tumors. Its contributions to neurosurgical diagnosis. J Neurosurg 1984; 60: 1121-33.
4. Brat DJ, Castellano-Sanchez A, Kaur B, Van Meir EG. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol 2002; 9: 24-36.
5. Brockes JP, Lemke GE, Balzer DR Jr. Purification and preliminary characterization of a glial growth factor from the bovine pituitary. J Biol Chem 1980; 255: 8374-7.
6. Chiu FC, Goldman JE. Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states. J Neuroimmunol 1985; 8: 283-92.
7. Chumbalkar VC, Subhashini C, Dhople VM, Sundaram CS, Jagannadham MV, Kumar KN, et al. Differential protein expression in human gliomas and molecular insights. Proteomics 2005; 5: 1167-77.
8. Cochran AJ, Wen DR. S-100 protein as a marker for melanocytic and other tumours. Pathology 1985; 17: 340-5.
9. Doetsch F. The glial identity of neural stem cells. Nat Neurosci 2003; 6: 1127-34.
10. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000; 25: 1439-51.
11. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res 1971; 28: 351-4.
12. Fischer W, Heller T, Herrmann E, Schreiber D. [A simple method for the isolation of GFAP and its use for the study of brain tumors]. Zentralbl Allg Pathol 1989; 135: 33-41.
13. Foerch C, Curdt I, Yan B, Dvorak F, Hermans M, Berkefeld J, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006; 77: 181-4.
14. Fukuda ME, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y, et al. Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res 2005; 65: 5190-4.
15. Gottschalk J, Szymas J. [Significance of immunohistochemistry for neurooncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors]. Zentralbl Allg Pathol 1987; 133: 319-30.
16. Gronowitz JS, Kallander CF, Hagberg H, Persson L. Deoxythymidinekinase in cerebrospinal fluid: a new potential "marker" for brain tumours. Acta Neurochir (Wien) 1984; 73: 1-12.
17. Hamaya K, Doi K, Tanaka T, Nishimoto A. The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases. Acta Med Okayama 1985; 39: 453-62.
18. Herpers MJ, Ramaekers FC, Aldeweireldt J, Moesker O, Slooff J. Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas. Acta Neuropathol (Berl) 1986; 70: 333-9.
19. Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003; 21: 177-90.
20. Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J, Baumann NA. Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci 1978; 35: 147-55.
21. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-68.
22. Kleihues P, Cavanee WK. World Health Organization: classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press; 2000.
23. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 44-51.
24. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304-5.
25. Lee K, Jeon K, Kim JM, Kim VN, Choi DH, Kim SU, et al. Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus. Glia 2005; 51: 1-12.
26. Lim R, Mitsunobu K. Brain cells in culture: morphological transformation by a protein. Science 1974; 185: 63-6.
27. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 1999; 45: 138-41.
28. Morrison RS, De Vellis J, Lee YL, Bradshaw RA, Eng LF. Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J Neurosci Res 1985; 14: 167-76.
29. Murphy KG, Hatton JD, Hoi Sang U. Role of glial fibrillary acidic protein expression in the biology of human glioblastoma U-373MG cells. J Neurosurg 1998; 89: 997-1006.
30. Oh D, Prayson RA. Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study. Arch Pathol Lab Med 1999; 123: 917-20.
31. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004; 57: 1006-12.
32. Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, et al. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 1997; 87: 420-30.
33. Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa EG. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma. Cancer Control 2004; 11: 174-80.
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96.
35. Taomoto K, Kokunai T, Okuda T, Tamaki N, Matsumoto S, Hashimoto N. [The value of neuron specific enolase (NSE) in patients with brain tumors]. No To Shinkei 1987; 39: 169-73.
36. Voorhies RM, Sundaresan N, Thaler HT. The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg 1980; 53: 364-8.
37. Yen SH, Dahl D, Schachner M, Shelanski ML. Biochemistry of the filaments of brain. Proc Natl Acad Sci USA 1976; 73: 529-33.
38. Zheng PP, Hop WC, Sillevis Smitt PA, van den Bent MJ, Avezaat CJ, Luider TM, et al. Low-molecular weight caldesmon as a potential serum marker for glioma. Clin Cancer Res 2005; 11: 4388-92.
39. Zhou R, Skalli O. TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 2000; 254: 269-78.
40. Zülch. Brain tumors. Their biology and pathology. Berlin: Springer; 1986.